These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 741952)

  • 1. [Relationships between magnesium and parathyroid hormone metabolism in healthy subjects, patients with chronic kidney failure and permanent dialysis patients].
    Samizadeh A; Wessels F; Losse H
    Verh Dtsch Ges Inn Med; 1978; (84):1294-7. PubMed ID: 741952
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnesium in dialysis patients: serum levels and clinical implications.
    Navarro-González JF
    Clin Nephrol; 1998 Jun; 49(6):373-8. PubMed ID: 9696434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic renal failure and magnesium metabolism.
    Lindeman RD
    Magnesium; 1986; 5(5-6):293-300. PubMed ID: 3807422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive parathyroid hormones in the circulation and cerebrospinal fluid from patients with renal failure: possible restriction of parathyroid hormone by the blood-brain barrier.
    Hironaka T; Morimoto S; Fukuo K; Koh E; Imanaka S; Sumida T; Onishi T; Kumahara Y
    Bone Miner; 1987 Sep; 2(6):487-94. PubMed ID: 3505771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
    Pabico RC; Rivero AJ; McKenna BA; Freeman RB
    Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced angiotensin II induced vascular reactivity in chronic renal failure.
    Jespersen B; Pedersen EB; Christensen NJ; Danielsen H; Sørensen SS
    Scand J Clin Lab Invest; 1988 Nov; 48(7):705-13. PubMed ID: 3201105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcitonin in hemodialysis patients].
    Augustin R; Hackeng WH
    MMW Munch Med Wochenschr; 1978 Feb; 120(6):173-4. PubMed ID: 305533
    [No Abstract]   [Full Text] [Related]  

  • 8. Parathyroid hormone (PTH) metabolism in chronic renal disease (CRD).
    Hruska K; Kopelman R; Rutherford WE; Greenwalt A; Klahr S; Slatopolsky E
    Proc Eur Dial Transplant Assoc; 1975; 11():457-64. PubMed ID: 1197270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gastric acid secretion and calcium metabolism in patients with chronic hemodialysis].
    Fendler JP; Khazine F; Dongradi G; Cassan P; Beaugrand M; Salmon D
    J Urol Nephrol (Paris); 1978 Sep; 84(9):658-63. PubMed ID: 748587
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agonistic effect of calcitonin against parathormone in patients with chronic renal insufficiency on hemodialysis].
    Rico Lenza H; Huertas García-Alejo R; del Rio Vázquez A; Espinos Pérez D
    Rev Clin Esp; 1981 Sep; 162(6):271-4. PubMed ID: 7330322
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
    El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
    Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone metabolism in man: effect of nephrectomy.
    Melick RA; Martin TJ
    Clin Sci; 1969 Dec; 37(3):667-74. PubMed ID: 5391606
    [No Abstract]   [Full Text] [Related]  

  • 14. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment.
    Chen J; Zhang J; Lin S
    Chin Med J (Engl); 1998 Jan; 111(1):24-7. PubMed ID: 10322647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular magnesium depletion in chronic renal failure.
    Lim P; Dong S; Khoo OT
    N Engl J Med; 1969 May; 280(18):981-4. PubMed ID: 5777924
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis.
    Navarro-González JF; Mora-Fernández C; García-Pérez J
    Semin Dial; 2009; 22(1):37-44. PubMed ID: 19250445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomagnesemia and hypermagnesemia.
    Massry SG; Seelig MS
    Clin Nephrol; 1977 Apr; 7(4):147-53. PubMed ID: 858210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy.
    McGonigle RJ; Weston MJ; Keenan J; Jackson DB; Parsons V
    Magnesium; 1984; 3(1):1-7. PubMed ID: 6482508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone assay drift: an unappreciated problem in dialysis patient management.
    Cantor T
    Semin Dial; 2005; 18(5):359-64. PubMed ID: 16191171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium absorption and metabolism in patients with chronic renal failure and in patients with normal renal function.
    Spencer H; Lesniak M; Gatza CA; Osis D; Lender M
    Gastroenterology; 1980 Jul; 79(1):26-34. PubMed ID: 7380219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.